Cellistic at the ISSCR PSC-Derived Symposium

Published on December 11, 2025
Cellistic_TL_Posters at ISSCR 25

Cellistic participates in this year’s ISSCR PSC-Derived Symposium, a gathering for innovators working to advance pluripotent stem cell technologies toward clinical impact. The meeting provides an opportunity to share how Cellistic's platforms are helping developers overcome two persistent challenges in the allogeneic cell therapy space:

(1) generating clinically compliant iPSC starting materials, and
(2) establishing scalable, reproducible manufacturing processes.

Continue reading on website
Other news

SelectScience E-Book: Understanding the Complex Landscape of Bioconjugates

December 10, 2025
A complete guide for selecting the right fit-for-purpose strategy for your ADC, AOC, and RDCBioconjugates are a rapidly expanding therapeutic modality demonstrating tremendous benefit for cancer patients already, and with significant promise in inflammatory, infectious, and rare diseases. Key to the successful development of bioconjugates is the selection of an appropriate conjugation strategy.In

Norstella and Replit team up to accelerate innovation and optimize commercial processes with AI

December 11, 2025
Innovation at Norstella often begins with a question: What if we could move faster—without sacrificing quality or compliance? During a recent hackathon, Norstella’s commercial and product teams had a chance to answer that question firsthand and help us drive our mission of improving patient access to lifesaving therapies across the drug development cycle by using […]